SCHEMBL4279282

SCHEMBL4279282

COCc1[c]noc1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1515234 0.68
SCHEMBL10388541 0.65 KCNH2 (0.37)
SCHEMBL2040164 0.65
SCHEMBL2203231 0.62
SCHEMBL4926603 0.61 KDM5A (0.32)
SCHEMBL1850398 0.60
SCHEMBL4925967 0.58 MAOA (0.33)
SCHEMBL3150716 0.58
SCHEMBL1937522 0.58
SCHEMBL12491093 0.58

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0150433-B1 PROCESS FOR THE PREPARATION OF INSATURATED KETONES BASF Aktiengesellschaft (DE) 1986-12-30 EP claimed
EP-0150433-A2 Process for the preparation of insaturated ketones BASF Aktiengesellschaft (DE) 1985-08-07 EP claimed
EP-3893871-B1 BENZIMIDAZOLONE DERIVATIVES, AND ANALOGUES THEREOF, AS IL-17 MODULATORS UCB Biopharma SRL (BE) 2024-04-10 EP disclosed
US-11458124-B2 Spirocyclic indane analogues as IL-17 modulators UCBBiopharma Srl (BE) 2022-10-04 US disclosed
US-20210380573-A1 Benzimidazolone Derivatives, and Analogues Thereof, as IL-17 Modulators UCB BIOPHARMA SRL (SOCIETE A RESPONSABILITE LIMITEE) (BE) 2021-12-09 US disclosed
US-20210228547-A1 Spirocyclic Indane Analogues as IL-17 Modulators UCB BIOPHARMA SRL (SOCIETE A RESPONSABILITE LIMITEE) (BE) 2021-07-29 US disclosed
US-11052076-B2 Spirocyclic indolines as IL-17 modulators UCB Biopharma SRL (BE) 2021-07-06 US disclosed
EP-3820567-A1 SPIROCYCLIC INDANE ANALOGUES AS IL-17 MODULATORS UCB Biopharma SRL (BE) 2021-05-19 EP disclosed
US-20200138797-A1 Spirocyclic Indolines as IL-17 Modulators UCB Biopharma SRL (BE) 2020-05-07 US disclosed
EP-3638227-A1 SPIROCYCLIC INDOLINES AS IL-17 MODULATORS UCB Biopharma SRL (BE) 2020-04-22 EP disclosed
WO-2020011731-A1 SPIROCYCLIC INDANE ANALOGUES AS IL-17 MODULATORS UCB Biopharma SRL (BE) 2020-01-16 WO disclosed
US-20090176307-A1 Compounds, Compositions and Methods CYTOKINETICS, INC. 2009-07-09 US disclosed
US-7491826-B2 Compounds, compositions and methods CYTOKINETICS, INC. (US) 2009-02-17 US disclosed
US-7399866-B2 Compounds, compositions, and methods CYTOKINETICS, INC. (US) 2008-07-15 US disclosed
US-20060241110-A1 Compounds, compositions, and methods CYTOKINETICS, INCORPORATED 2006-10-26 US disclosed
US-20050159416-A1 Compounds, compositions and methods CYTOKINETICS, INCORPORATED 2005-07-21 US disclosed
EP-0579810-A1 NOVEL PYRETHRINOID ESTERS DERIVED FROM ISOXAZOLIC OR ISOTHIAZOLIC ALCOHOL, PREPARATION METHOD THEREFOR AND USE THEREOF AS PESTICIDES ROUSSEL UCLAF (FR) 1994-01-26 EP disclosed
WO-1993016054-A1 NOVEL PYRETHRINOID ESTERS DERIVED FROM ISOXAZOLIC OR ISOTHIAZOLIC ALCOHOL, PREPARATION METHOD THEREFOR AND USE THEREOF AS PESTICIDES ROUSSEL-UCLAF (FR) 1993-08-19 WO disclosed
EP-0150433-B1 PROCESS FOR THE PREPARATION OF INSATURATED KETONES BASF Aktiengesellschaft (DE) 1986-12-30 EP disclosed
EP-0150433-A2 Process for the preparation of insaturated ketones BASF Aktiengesellschaft (DE) 1985-08-07 EP disclosed